期刊文献+

术前外周血中性粒细胞/淋巴细胞比值在结直肠癌预后评估中的价值 被引量:18

Assessment value of preoperative neutrophil-lymphocyte ratio for the prognosis of patients with colorectal cancer after radical operation
原文传递
导出
摘要 目的探讨术前外周血中性粒细胞/淋巴细胞比值(NLR)对结直肠癌患者预后评估的价值。方法回顾性分析2005年7月至2011年7月问在解放军总医院普通外科接受根治性手术且术后随访资料完整的140例结直肠癌患者的临床资料。根据患者术前外周血NLR分为低NLR组(小于5,105例)和高NLR组(大于或等于5,35例),比较两组患者的术后5年生存率并进行预后分析。结果低NLR组和高NLR组结直肠癌患者术后5年生存率分别为74-8%和54.7%,差异有统计学意义(P=0.03)。单因素分析显示,术前NLR、肿瘤位置、浸润深度、淋巴结转移及肿瘤分期与本组患者术后生存有关(P〈0.05和P〈0.01);多凶素预后分析证实,NLR是影响本组结直肠癌患者预后的独立危险因素(RR=I.068,95%c1:1.009~1.129,P=0.02)。结论术前NLR大于或等于5提示结直肠癌患者预后较差。 Objective To assess the value of preoperative neutrophil-lymphocyte ratio(NLR) for prognosis in patients with colorectal cancer after radical operation. Methods Clinical data of 140 patients with colorectal cancer undergoing radical operation in the Department of General Surgery of General Hospital of PLA from July 2005 to July 2011 were analyzed retrospectively. According to preoperative NLR, patients were divided into the low NLR group(NLR〈5, n=105) and the high NLR group (NLR~〉5, n=35). The overall 5-year survival rates of two groups were compared and the independent risk factors were examined by univariate analysis and Cox model. Results The overall 5-year survival rates of the low and high NLR groups were 74.8% and 54.7% respectively with significant differencre (P=0.03). Univariate analysis revealed depth of tumor, lymph nodes metastasis, TMN stage and NLR were associated with survival(P〈0.05, P〈0.01). C model showed that NLR was independent risk factor of prognosis (RR = 1.068, 95 % CI: 1.009-1.129, P=0.02). Conclusion Preoperative NLRt〉5 predicts poorer prognosis of colorectal cancer patients.
出处 《中华胃肠外科杂志》 CAS CSCD 2013年第8期723-726,共4页 Chinese Journal of Gastrointestinal Surgery
关键词 结直肠肿瘤 中性粒细胞 淋巴细胞比值 预后 Colorectal neoplasms Neutrophil-lymphocyte ratio Prognosis
  • 相关文献

参考文献15

  • 1中华医学会外科学分会胃肠外科学组,结直肠肛门外科学组,中国抗癌协会大肠癌专业委员会.结直肠癌肝转移诊断和综合治疗指南(V20LO).中华胃肠外科杂志,2010,13:457-470.
  • 2Coussens LM, Werb Z. Inflammation and cancer. Nature, 2002, 420 : 860-867.
  • 3Sarraf KM, Belcher E, Raevsky E, et al. Neutrophil/ lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thoac Cardiovas Surg, 2009,137 : 425-428.
  • 4汪国营,杨扬,张琪,李华,陈冠中,易述红,许赤,汪根树,张剑,易慧敏,姜楠,傅斌生,赵辉,李敏如,陈颖华,蔡常洁,陆敏强,陈规划.术前中性粒细胞与淋巴细胞比值对肝癌肝移植术后肿瘤复发的影响[J].中华医学杂志,2011,91(22):1519-1522. 被引量:9
  • 5马晋平,王智,林建伟,吴恺明,陈剑辉,陈创奇,蔡世荣,何裕隆,詹文华.中性粒细胞/淋巴细胞比值在胃癌预后评估中的应用[J].中华胃肠外科杂志,2011,14(12):944-947. 被引量:34
  • 6陈创奇,方乐堃,马晋平,蔡世荣,董文广,黄奕华,何裕隆,詹文华.结直肠癌2042例临床病理特点及预后回归分析[J].中华医学杂志,2010,90(26):1804-1807. 被引量:33
  • 7陈钰锋,曾杨,何晓生,吴现瑞,袁瑞学,宋盛平,兰平,吴小剑.影响Ⅱ期结直肠癌患者预后的临床病理因素分析[J].中华消化外科杂志,2011,10(6):430-435. 被引量:11
  • 8Maltoni M, Caraeeni A, Brunelli C, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol, 2005, 23 : 6240-6248.
  • 9Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature, 2008,454 : 436-444.
  • 10Leung EY, Scott HR, McMillan DC. Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer. J Thorac Oncol, 2012, 7 : 655-662.

二级参考文献66

  • 1张明刚,李靖涛,杨华元,赵洪川.1134例大肠癌临床病例分析[J].中华医学杂志,2003,83(23):2087-2088. 被引量:33
  • 2樊嘉,徐泱,周俭.肝癌患者肝移植适应证的选择[J].中华医学杂志,2005,85(24):1662-1664. 被引量:23
  • 3许岸高,姜泊,钟旭辉,刘集鸿.广东地区3870例大肠癌的临床流行病学特征[J].中华内科杂志,2006,45(1):9-12. 被引量:35
  • 4贺轶锋,樊嘉,周俭,吴志全,邱双健,黄晓武,余耀,孙健,肖永胜,杨国欢,宋康,王征,汤钊猷,王玉琦.影响肝癌肝移植预后的高危因素分析及诊治经验[J].中华医学杂志,2006,86(18):1232-1235. 被引量:27
  • 5Chiang JM,Chen MC,Changchien CR,et al.Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma:patients 30 years of age or younger may be a distinct patient group.Dis Colon Rectum,2003,46:904-910.
  • 6Chew MH,Koh PK,Ng KH,et al.Improved survival in an Asian cohort of young colorectal cancer patients; an analysis of 523 patients from a single.Int J Colorectal Dis,2009,24:1075-1083.
  • 7Chung YF,Eu KW,Machin D,et al.Young age is not a poor prognostic marker in colorectal cancer.Br J Surg,1998,85:1255-1259.
  • 8Zlobec I,Lugli A.Prognostic and predictive factors in colorectal cancer.J Clin Pahto,2008,61:561-569.
  • 9Compton CC.Optimal pathologic staging:defining stage II disease.Clin Cancer Res,2007,13:6862s-6870s.
  • 10徐泱,樊嘉,周俭,邱双健,吴志全,余耀,黄晓武,汤钊猷,王玉琦.肝癌肝移植预后相关因素分析[J].中华医学杂志,2007,87(30):2101-2104. 被引量:6

共引文献81

同被引文献149

引证文献18

二级引证文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部